J&J Will Sell Diagnostics Division to Carlyle Group

Johnson & Johnson said it would sell its ortho clinical diagnostics division to the Carlyle Group LP for $4.15 billion, shedding a slow-growing business to focus on more lucrative products. The unit includes laboratory diagnostics products and blood-transfusion-screening equipment, and it has operations in 130 countries. The acquisition is expected to be finalized in mid-2014. Read the full story

More News:

All news »

What are your comments?

Join the discussion today. Login Here.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments